BI
SWTX

BVF Inc’s SpringWorks Therapeutics SWTX Stock Holding History

BVF Inc’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50
Closed -$4K – 73
2020
Q4 		$4K Sell
50
-2,053,941
-100% -$132M ﹤0.01% 68
2020
Q3 		$97.9M Sell
2,053,991
-232,900
-10% -$9.92M 5.33% 2
2020
Q2 		$96M Sell
2,286,891
-480,739
-17% -$17.1M 5.92% 1
2020
Q1 		$74.7M Sell
2,767,630
-311,525
-10% -$10.2M 6.96% 4
2019
Q4 		$119M Buy
3,079,155
+235,010
+8% +$5.5M 8.99% 2
2019
Q3 		$61.7M Buy
+2,844,145
New +$67.2M 6.48% 2

Other funds holding SWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BVF Inc's SWTX Position: Q1 2021 in Review

BVF Inc sold out of SpringWorks Therapeutics (SWTX) in Q1 2021, closing a stake of 50 shares — an estimated $4K sold.

BVF Inc first reported a position in SWTX in Q3 2019 and held it in 6 quarters. The position peaked at $119M in Q4 2019. 137 funds tracked by Wall St. Rank hold SWTX as of Q1 2021.

  • BVF Inc reported no remaining SpringWorks Therapeutics position as of Q1 2021 after selling out during the quarter.
  • BVF Inc sold 50 SpringWorks Therapeutics shares in Q1 2021, an estimated $4K.
  • BVF Inc first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 6 quarters.
  • BVF Inc's SpringWorks Therapeutics position peaked at $119M in Q4 2019.
  • 137 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2021.

Based on BVF Inc's 13F filing for Q1 2021, filed 17 May 2021.